Trial Profile
Efficacy and safety of Golimumab for the treatment of ulcerative colitis: a real life, prospective, cohort study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2017
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 08 Dec 2017 New trial record
- 01 Nov 2017 Results presented at the 25th United European Gastroenterology Week